Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Glennie

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Immunology Today|August 1, 2000
Clinical trials of antibody therapyM J Glennie, P W Johnson
Cancer Surveys|January 1, 1985
Surface immunoglobulin of B-lymphocytic tumours as a therapeutic targetG T Stevenson, M J Glennie
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1991
Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cellsA Tutt, G T Stevenson, M J Glennie
Current Opinion in Immunology|October 6, 1999
Signaling antibodies in cancer therapyM S Cragg, R R French, M J Glennie
European Journal of Immunology|October 10, 2001
Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154L E Haswell, M J Glennie, A Al-Shamkhani
Scandinavian Journal of Immunology|August 1, 1992
Cytoplasmic calcium fluxes induced in cytotoxic effector cells by engagement of Fc gamma receptors I, II, and IIIS J Curnow, M J Glennie, G T Stevenson
Journal of Immunological Methods|June 14, 1995
Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensorA J George, R R French, M J Glennie
Chemical Immunology|January 1, 1990
Anti-idiotypic therapy of leukemias and lymphomasF K Stevenson, A J George, M J Glennie
Cancer Immunology, Immunotherapy : CII|January 1, 1993
The role of apoptosis in antibody-dependent cellular cytotoxicityS J Curnow, M J Glennie, G T Stevenson
European Journal of Immunology|June 1, 1991
Bispecific F(ab'gamma)3 antibody derivatives for redirecting unprimed cytotoxic T cellsA Tutt, J Greenman, G T Stevenson, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Immunology Today|August 1, 2000
Clinical trials of antibody therapyM J Glennie, P W Johnson
Cancer Surveys|January 1, 1985
Surface immunoglobulin of B-lymphocytic tumours as a therapeutic targetG T Stevenson, M J Glennie
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1991
Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cellsA Tutt, G T Stevenson, M J Glennie
Current Opinion in Immunology|October 6, 1999
Signaling antibodies in cancer therapyM S Cragg, R R French, M J Glennie
European Journal of Immunology|October 10, 2001
Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154L E Haswell, M J Glennie, A Al-Shamkhani
Scandinavian Journal of Immunology|August 1, 1992
Cytoplasmic calcium fluxes induced in cytotoxic effector cells by engagement of Fc gamma receptors I, II, and IIIS J Curnow, M J Glennie, G T Stevenson
Journal of Immunological Methods|June 14, 1995
Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensorA J George, R R French, M J Glennie
Chemical Immunology|January 1, 1990
Anti-idiotypic therapy of leukemias and lymphomasF K Stevenson, A J George, M J Glennie
Cancer Immunology, Immunotherapy : CII|January 1, 1993
The role of apoptosis in antibody-dependent cellular cytotoxicityS J Curnow, M J Glennie, G T Stevenson
European Journal of Immunology|June 1, 1991
Bispecific F(ab'gamma)3 antibody derivatives for redirecting unprimed cytotoxic T cellsA Tutt, J Greenman, G T Stevenson, et al.
Pageof 7